Trial Information
Summary: Maintenance of Benefit after 8 and 52-week Treatment for Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)
This is a medication trial in which all who qualify will receive
a non-stimulant medication for ADHD and will be assessed for
improvement in family functioning, academic performance, grade
point average, and health outcomes.
Compensation Provided
Patient Inclusion/Exclusion Criteria:
Males and Females ages 13-16
Weight between 88 and 154 lbs.
Must meet criteria for ADHD
In good general health
Pregnant or nursing females
Adolescents who are doing well with their current ADHD
treatment
|
Contact:
Robyn C Palmero, M.A.
Mount Sinai Medical Center
One Gustave L. Levy Place
New York, NY 10029
Telephone: 212-659-8833
Fax: 212-849-2690
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 5:43:56 AM